FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Pack Pharmaceuticals Ciprofloxacin Tablets Recall

Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in In…

Pack Pharmaceuticals · Buffalo Grove, IL

Risk level
Class III
Reported by FDA
Jul 25, 2012
Recall ID
D-1422-2012
Check your lot numberHow we source this data

Summary

Pack Pharmaceuticals recalled Ciprofloxacin Tablets starting Mar 9, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1422-2012 on Jul 25, 2012. Reason: Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels. Status: Terminated.

Why it was recalled

Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.

Product description

Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10.

Lot numbers, UPCs & expiration codes

Lot #: : PUB1040, Exp 08/2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1422-2012
Classification
Class III
Status
Terminated
Recall initiated
Mar 9, 2012
FDA report date
Jul 25, 2012
Quantity
4,848 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Pack Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-1422-2012, exactly as published.

Show all FDA fields
City
Buffalo Grove
State
IL
Status
Terminated
Country
United States
Event ID
51880
Address
1110 W Lake Cook Rd
Address (line 2)
Ste 301
Code information
Lot #: : PUB1040, Exp 08/2015
Postal code
60089-1944
Report date
Jul 25, 2012
Product type
Drugs
Recall number
D-1422-2012
Classification
Class III
Recalling firm
Pack Pharmaceuticals
Product quantity
4,848 bottles
Termination date
Jul 19, 2012
Reason for recall
Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10.
Distribution pattern
Nationwide
Recall initiation date
Mar 9, 2012
Initial firm notification
Letter
Center classification date
Jul 19, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1422-2012, published Jul 25, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls